Page last updated: 2024-12-10

n-(9-acridinyl)maleimide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(9-acridinyl)maleimide: used for determination of carnitine palmitoyltransferase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3016496
SCHEMBL ID722543
MeSH IDM0215051

Synonyms (19)

Synonym
BIDD:GT0575
n-(9-acridinyl)maleimide
9-maleimidoacridine
49759-20-8
FT-0639886
1-acridin-9-ylpyrrole-2,5-dione
inchi=1/c17h10n2o2/c20-15-9-10-16(21)19(15)17-11-5-1-3-7-13(11)18-14-8-4-2-6-12(14)17/h1-10h
ncfikbmpeoeied-uhfffaoysa-
1h-pyrrole-2,5-dione, 1-(9-acridinyl)-
1-acridin-9-ylpyrrole-2,5-dione;1-(acridin-9-yl)-1h-pyrrole-2,5-dione
A827841
1-(acridin-9-yl)-1h-pyrrole-2,5-dione
SCHEMBL722543
DTXSID80198030
mfcd00042983
AKOS027320477
1-(acridin-9-yl)-2,5-dihydro-1h-pyrrole-2,5-dione
AS-63214
F16670
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (60.00)18.2507
2000's4 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.80 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]